Figure 7.

(A) Schematic diagram of the preparation of SFN-CDDP-NPs for improved anti-tumor therapy. Adapted with permission from ref 110, copyright 2020 American Chemical Society. (B) Illustration of the redox-responsive nanoplatform, composed of Pt(IV) prodrug 5, Cys-8E polymer, and lipid-PEG, for in vivo Pt delivery and treatment of cisplatin-resistant tumors. Adapted with permission from ref 111, copyright 2018 American Chemical Society. (C) Schematic illustration of phospholipid-mimic CBP-LA conjugates that self-assemble into micelle-like nanoparticles and the possible mechanism of their anti-cancer activity. Adapted with permission from ref 112, copyright 2018 Royal Society of Chemistry.